RVL Pharmaceuticals PLC (FRA:O1P)
€ 0.003 0 (0%) Market Cap: 1.65 Mil Enterprise Value: 38.48 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Osmotica Pharmaceuticals PLC Announces Definitive Agreement with Alora Pharmaceuticals LLC Transcript

Jun 25, 2021 / 12:30PM GMT
Release Date Price: €3.14 (+36.52%)
Operator

Good morning, ladies and gentlemen, and welcome to the Osmotica Strategic Sales Call. (Operator Instructions)

As a reminder, this conference call is being recorded. I would now like to turn the conference over to your first speaker today, Ms. Judy DiClemente. Thank you. Please go ahead.

Judy DiClemente

Thank you, Stacy. Welcome to Osmotica Pharmaceuticals call regarding the sale of its legacy business to Alora Pharmaceuticals, LLC. This is Judy DiClemente, Investor Relations for Osmotica. With me on today's call are Osmotica's Chief Executive Officer, Brian Markison; Chief Operating Officer, JD Schaub; and Chief Financial Officer, Andrew Einhorn. This morning, the company issued a press release for the sale of its legacy business to Alora Pharmaceuticals, LLC. This press release and a webcast of this call can be accessed through the Investors Section of the Osmotica website at osmotica.com.

Before we get started, I would like to remind everyone that any statements made on today's conference call that express a belief, expectation, projection,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot